News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invocare.
RELATED STOCKHEAD STORIES
News
UBS is Fed up, so consume this sector with some discretion
News
Here are the top ASX large cap movers for Monday
News
Short and Caught: ASX investors are shorting Invocare, Bravura, EOS and EML
Director Trades
Directors’ Trades: Who bought their company’s ASX shares on market just 2 days post-IPO?
News
Trading Places: Fund managers have been buying these ASX food delivery stocks this week
Health & Biotech
Your ultimate guide to ASX pet stocks
Experts
MoneyTalks: Morningstar reckons this ASX stock could be a half-price bargain
News
Missing dividends? Morningstar thinks they’ll be back (eventually)
News
Divorce lawyers plan for COVID-19 surge in business
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
News
11 small caps caught in ASIC annual report snare
Health & Biotech
Health: Pharmaxis tumbles way into the red as fortunes fluctuate on handballed drug
Health & Biotech
